Natixis’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,200
Closed -$981K 1072
2024
Q1
$981K Hold
6,200
0.01% 528
2023
Q4
$972K Hold
6,200
0.01% 528
2023
Q3
$966K Buy
+6,200
New +$1.02M 0.01% 504
2022
Q4
Sell
-706
Closed -$116K 1224
2022
Q3
$116K Sell
706
-547
-44% -$92.6K ﹤0.01% 990
2022
Q2
$220K Buy
+1,253
New +$223K ﹤0.01% 1021

Other funds holding JNJ

Natixis's JNJ Position: Q1 2026 in Review

Natixis reduced its Johnson & Johnson (JNJ) stake by 48% in Q1 2026, selling an estimated $45.6M and leaving 213,825 shares worth $52.3M. The position accounts for 0.19% of the portfolio, ranked #77.

Natixis first reported a position in JNJ in Q2 2013 and has held it in 51 quarters since. The position peaked at $355M in Q3 2017. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Natixis held 213,825 shares of Johnson & Johnson worth $52.3M as of Q1 2026.
  • Natixis sold 195,918 Johnson & Johnson shares in Q1 2026, an estimated $45.6M.
  • Johnson & Johnson made up 0.19% of Natixis's portfolio in Q1 2026, its #77 holding.
  • Natixis first reported a position in Johnson & Johnson in Q2 2013 and has held it in 51 quarters since.
  • Natixis's Johnson & Johnson position peaked at $355M in Q3 2017.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Natixis's 13F filing for Q1 2026, filed 14 May 2026.